BeginnerSelf-pacedNo New Dates

Navigating Scope of Practice for Ketamine-Assisted Psychotherapy (KAP)

Navigating Scope of Practice for Ketamine-Assisted Psychotherapy (KAP) is designed for mental health professionals interested in learning about the latest developments in ketamine-assisted psychotherapy and its scope of practice.

Provider

English

Details

1 Hours
1 modules

Enrollment

$25
This course is currently marked as no new dates.

Course Overview

Navigating Scope of Practice for Ketamine-Assisted Psychotherapy (KAP) is designed for mental health professionals interested in learning about the latest developments in ketamine-assisted psychotherapy and its scope of practice.

The course will bring together industry leaders, including Fluence, Journey Clinical, Bruce Hillowe, and the Psychedelic Coalition for Health, for a roundtable discussion on the topic. Participants will gain a better understanding of the use of ketamine as an adjunct to psychotherapy, the eligibility criteria for patients, and the role of a licensed mental health professional in KAP.

The course will also provide insights into the challenges faced by all stakeholders, including insurance providers and patients, in navigating the scope of practice for KAP. By the end of the course, participants will have a clearer understanding of the current state of KAP and its future potential as a therapeutic modality.

About the Provider

Fluence is a psychedelic therapy education company offering Professional Certificates and courses for psychedelic therapy, ketamine-assisted psychotherapy, psilocybin facilitation, harm reduction, and integration. Its current public catalog centers on Essentials of Psychedelic Therapy, Introduction to Psychedelic Therapy, and Professional Certificates in Psychedelic Harm Reduction and Integration Therapy, Ketamine-Assisted Psychotherapy, and Psilocybin Facilitation.

View Fluence profile

Course Details

  • Price$25
  • FormatSelf-paced
  • Lifecycle statusNo New Dates
  • Skills
    regulatory process for psychedelic-therapiesapproval process for PATcolonization and drug policy
  • Categories